GSK plc (NYSE:GSK) today reports that the US Food and Drug Administration (FDA) granted full approval for Jemperli (dostarlimab-gxly) for the treatment of adult patients with mismatch repair-deficient (dMMR) recurrent or advanced endometrial cancer, as determined by a US FDA-approved test, that has progressed on or following a prior platinum-containing regimen in any setting and are not candidates for curative surgery or radiation.
PacWest Bancorp Stock Is Down, But Off The Lows: What’s Going On?
PacWest Bancorp (NASDAQ: PACW) shares are plunging Thursday after the bank said it's weighing strategic options, which reportedly includes
